Literature DB >> 20522571

Interpreting lung function data using 80% predicted and fixed thresholds misclassifies more than 20% of patients.

Martin R Miller1, Philip H Quanjer, Maureen P Swanney, Gregg Ruppel, Paul L Enright.   

Abstract

BACKGROUND: Differences in COPD classification have been shown in population data sets when using fifth percentiles as the lower limit of normal (LLN) vs the current GOLD (Global Initiative for Chronic Obstructive Lung Disease) guidelines of FEV(1)/FVC < 0.70 for detecting airway obstruction and an FEV(1) of 80% predicted for detecting and classifying the severity of COPD (GOLD/PP). Many lung function laboratories use 80% predicted to determine whether results are abnormal. Misclassification of the full range of lung diseases in large patient groups when using GOLD/PP criteria instead of the LLN has not been explored previously.
METHODS: We determined the discrepancy rates in pulmonary function test interpretation between the GOLD/PP and LLN methods on prebronchodilator lung function results from a large number of adult patients from the United Kingdom, New Zealand, and the United States.
RESULTS: In 11,413 patients, the GOLD/PP method misclassified 24%. Ten percent of patients who had normal lung function were falsely classified with a disease category, and 7% of patients were falsely attributed with emphysema. The GOLD/PP method gave false-positive classifications for airflow obstruction and restrictive defects to significantly more men (P < .01) and older patients (P < .0001) and also missed airflow obstruction and restrictive defects in younger patients (P < .0001).
CONCLUSIONS: Using lung function tests on their own with 80% predicted and fixed cut points to determine whether a test is abnormal could misdiagnose > 20% of patients referred for pulmonary function tests. The GOLD/PP method introduces clinically important biases in assessing disease status that could affect allocation to treatment groups. This misclassification is avoided by using the LLN based on the fifth-percentile values.

Entities:  

Mesh:

Year:  2010        PMID: 20522571     DOI: 10.1378/chest.10-0189

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  48 in total

1.  Reliability, validity and responsiveness to change of the Saint George's Respiratory Questionnaire in early diffuse cutaneous systemic sclerosis.

Authors:  Beth Wallace; Suzanne Kafaja; Daniel E Furst; Veronica J Berrocal; Peter A Merkel; James R Seibold; Maureen D Mayes; Dinesh Khanna
Journal:  Rheumatology (Oxford)       Date:  2015-02-09       Impact factor: 7.580

2.  ARTP statement on pulmonary function testing 2020.

Authors:  Karl Peter Sylvester; Nigel Clayton; Ian Cliff; Michael Hepple; Adrian Kendrick; Jane Kirkby; Martin Miller; Alan Moore; Gerrard Francis Rafferty; Liam O'Reilly; Joanna Shakespeare; Laurie Smith; Trefor Watts; Martyn Bucknall; Keith Butterfield
Journal:  BMJ Open Respir Res       Date:  2020-07

3.  Spirometry, Static Lung Volumes, and Diffusing Capacity.

Authors:  Carlos A Vaz Fragoso; Hilary C Cain; Richard Casaburi; Patty J Lee; Lynne Iannone; Linda S Leo-Summers; Peter H Van Ness
Journal:  Respir Care       Date:  2017-07-11       Impact factor: 2.258

4.  Re-evaluation of the Uplift Clinical Trial Using Age-Appropriate Spirometric Criteria.

Authors:  Carlos A Vaz Fragoso; Linda S Leo-Summers; Thomas M Gill; Gail J McAvay
Journal:  Chest       Date:  2020-04-09       Impact factor: 9.410

5.  Recovery of Pulmonary Function after Allogeneic Hematopoietic Cell Transplantation in Children is Associated with Improved Survival.

Authors:  Ashok Srinivasan; Anusha Sunkara; William Mitchell; Sudeep Sunthankar; Guolian Kang; Dennis C Stokes; Saumini Srinivasan
Journal:  Biol Blood Marrow Transplant       Date:  2017-09-01       Impact factor: 5.742

6.  Guidelines for diagnosis and management of chronic obstructive pulmonary disease: Joint ICS/NCCP (I) recommendations.

Authors:  Dheeraj Gupta; Ritesh Agarwal; Ashutosh Nath Aggarwal; V N Maturu; Sahajal Dhooria; K T Prasad; Inderpaul S Sehgal; Lakshmikant B Yenge; Aditya Jindal; Navneet Singh; A G Ghoshal; G C Khilnani; J K Samaria; S N Gaur; D Behera
Journal:  Lung India       Date:  2013-07

7.  Hyperpolarized 129Xenon Magnetic Resonance Imaging to Quantify Regional Ventilation Differences in Mild to Moderate Asthma: A Prospective Comparison Between Semiautomated Ventilation Defect Percentage Calculation and Pulmonary Function Tests.

Authors:  Lukas Ebner; Mu He; Rohan S Virgincar; Timothy Heacock; Suryanarayanan S Kaushik; Matthew S Freemann; H Page McAdams; Monica Kraft; Bastiaan Driehuys
Journal:  Invest Radiol       Date:  2017-02       Impact factor: 6.016

8.  Comparison of spirometric thresholds in diagnosing smoking-related airflow obstruction.

Authors:  Surya P Bhatt; Jessica C Sieren; Mark T Dransfield; George R Washko; John D Newell; Douglas S Stinson; Gideon K D Zamba; Eric A Hoffman
Journal:  Thorax       Date:  2013-03-23       Impact factor: 9.139

9.  Forced expiratory capnography and chronic obstructive pulmonary disease (COPD).

Authors:  Robert H Brown; Allison Brooker; Robert A Wise; Curt Reynolds; Claudio Loccioni; Adolfo Russo; Terence H Risby
Journal:  J Breath Res       Date:  2013-02-27       Impact factor: 3.262

10.  Multi-ethnic reference values for spirometry for the 3-95-yr age range: the global lung function 2012 equations.

Authors:  Philip H Quanjer; Sanja Stanojevic; Tim J Cole; Xaver Baur; Graham L Hall; Bruce H Culver; Paul L Enright; John L Hankinson; Mary S M Ip; Jinping Zheng; Janet Stocks
Journal:  Eur Respir J       Date:  2012-06-27       Impact factor: 16.671

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.